Meeting
2017 ASCO Annual Meeting
Price trajectories assessment for Medicare Part B generic anti-cancer drugs.
Authors
Noa Gordon
Davidoff Cancer Center, Petah Tikva, Israel
Noa Gordon , Omer Ben-Aharon , Salomon M. Stemmer , Dan Greenberg , Daniel A. Goldstein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 35, 2017 (suppl; abstr 6624)
DOI
10.1200/JCO.2017.35.15_suppl.6624
Abstract #
6624
Poster Bd #
446
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Time trends of Part D drug expenses and Part D risk adjustment in the Oncology Care Model at a community oncology network.
First Author: Puneeth Indurlal
Poster
2021 ASCO Quality Care Symposium
Physician-pharmacy integration and oral cancer drug use and quality.
First Author: Pragya Kakani
Poster
2024 ASCO Annual Meeting
Medicare reimbursement trends of biological reference agents and their biosimilars.
First Author: John Albaugh
Poster
2023 ASCO Quality Care Symposium
Does financial assistance reduce catastrophic spending for patients prescribed oral anti-cancer medications at an integrated Specialty Pharmacy?
First Author: Scott Swartz